Tag Archives: more

CIOs and innovation officers bolster clinical informatics, cyber defenses and more

When the COVID-19 pandemic struck, many IT leaders shadowed clinical staff to view first-hand the support those clinicians needed on the front lines. And often they learned some valuable lessons. Meanwhile, while healthcare organizations and their IT teams focused on fighting the COVID-19 crisis, hackers in the wild were not taking a break from their… Read More »

‘People scared of catching Covid more judgmental & disapproving, study finds’

Now here’s an interesting one. Apparently people who are scared of catching Covid are also the most judgmental and disapproving – and not just about being careless with ­restrictions, but any wrongdoing. Yes, researchers have been looking into how we make moral judgments and it appears our morality is closely linked to concerns about our… Read More »

Vendor Notebook: new acquisitions from Health Catalyst, Tegria and more

Health Catalyst announced June 24 that it will acquire Twistle, the company announced on June 24. Twistle’s SaaS-based patient engagement technology will bolster Health Catalyst’s existing population health analytics technology and help provider customers in their efforts to transition to accountable care, the company said. “Twistle is a leading healthcare technology company committed to developing… Read More »

Hormone Replacement Therapy for Men: Types & More

Hormone Replacement Therapy: Definition When we talk about hormone replacement therapy (HRT) in men, we’re talking about testosterone. A small amount of testosterone is produced in the adrenal glands, but for men the majority of testosterone is produced in the testicles. Testosterone has both physical and psychological benefits.1 Physically, the hormone has several functions for… Read More »

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

Gaining weight after switching to a new antiretroviral combination is common, especially after switching from efavirenz or the older formulation of tenofovir, but most weight gain is modest and occurs in the first year after switching, a review of 12 large clinical trials shows. The results suggest that some older antiretrovirals may have a weight-suppressive… Read More »